Sensipar
(cinacalcet) tablets
All edits
Edits on 7 Apr, 2022
Vitalii Mazuryk
Edits made to:
Description (+20 characters)
Article (+282 characters)
Sensipar
(cinacalcet) tablets
Article
Sensipar® (cinacalcet) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis.
Sensipar® should not be used in patients with CKD who are not on dialysis because of an increased risk of low calcium levels.
Vitalii Mazuryk
Edits made to:
Infobox (+2 properties)
Infobox
Industry
Product parent company
Vitalii Mazuryk
Edits made to:
Infobox (+2 properties)
Sensipar
(cinacalcet) tablets
Infobox
Is a
Website
Find more entities like Sensipar
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.